Skip to main content

Division of Hematology

The Division of Hematology offers expertise in the diagnosis and treatment of a broad spectrum of blood disorders and malignant diseases. The Hematology faculty participate in specialized patient care and research programs in the areas of solid tumors, hematologic malignancies, thrombosis, bleeding disorders, sickle cell anemia, and bone marrow transplantation. In association with other members of the UNC Blood Research Center and the UNC Lineberger Comprehensive Cancer Center, specialized interdisciplinary oncology clinics and conferences are held weekly in the areas of breast cancer, thoracic, gastrointestinal, genitourinary, sarcoma, neuro-oncology, melanoma, and head and neck malignancies. Centers which are central to implementing the patient care and research missions of the Division include the Lineberger Comprehensive Cancer Center, one of the foremost cancer research centers in the country, and the UNC Blood Research Center is nationally recognized in areas of Hemostasis and Thrombosis, Hemophilia, and Sickle Cell Centers.

Hematology News

  • Shakira-Grant-directory

    Featured Physician: Shakira J. Grant, MBBS

    Dr. Shakira Grant was born in Barbados and says she knew around the age of 11 or 12, when her grandfather was diagnosed with lung cancer, that she would become an oncologist. She also says UNC felt like home when she visited, and it was the “ease of conversation, welcoming smiles, and the collegial atmosphere” that helped her know UNC was the place to be.

  • Natalie Grover, MD

    Promising Therapy For Patients With Relapsed/Refractory Hodgkin Lymphoma

    Natalie Grover, MD, assistant professor in the division of hematology and clinical director of the cell therapy program in the Lineberger Comprehensive Cancer Center, discusses her research on anti-CD30 CAR-T therapy for patients with relapsed/refractory Hodgkin lymphoma in a new video featured on the Oncology Learning Network. Following is an excerpt from the transcript: “CAR-T … Continued

  • sickle-cell-clot

    Pawlinski, Key Awarded $2.8 Million Grant To Study VTE in Sickle Cell Disease

    Rafal Pawlinski, PhD, the Lenvil Lee Rothrock Distinguished Professor of Medicine, and Nigel Key, MD, the Harold R. Roberts Distinguished Professor, both professors in the department of medicine’s division of hematology and members of the UNC Blood Research Center, have been awarded a $2.8 million, 4-year R01 grant from the NIH-NHLBI to investigate the mechanism … Continued

More Hematology & Oncology News